Elite Pharmaceuticals Inc. (ELTP) fits nicely into the nexus of the increasing diagnoses of ADHD and the patent expiration of the branded drug Vyanse in 2023 for its treatment. Elite Pharmaceuticals Inc....
Zacks Investment Research has recently initiated coverage of Precipio, Inc. PRPO, assigning an "Outperform" recommendation to the company's shares. This bullish stance reflects the company's path to profitability...
Precipio prepares to launch a nationwide HemeScreen sales effort of 250+ sales reps from AmerisourceBergen, ThermoFisher, and other distributors ...
Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST...
Agreement Enhances Precipio’s Product Reach to US Laboratories...
Meeting Adjourned, new meeting set for July 5th at 10am EDT...
Seasoned, experienced industry executive with a track record of managing 9-figure revenue sales organizations...
This Regulatory Approval Opens the Company’s Reach to the European Market...